Xenex Stock

Xenex offers Pulsed Xenon Full Spectrum, a UV disinfection solution that reduces the bacterial load associated with the risk for HAIs.

Sign up today and learn more about Xenex Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Xenex Stock

Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections. The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load often associated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S. Xenex was founded in 2009 and headquartered in San Antonio, Texas.

Funding History

September 2012$9.2M
November 2013$11.3M
January 2015$25.0M
September 2016$3.0M
February 2017$38.0M
October 2018$5.0M



Morris Miller


Brian Cruver

Co-Founder, Chief Scientific Officer & Speaker

Mark Stibich

Co- Founder & Chief Epidemiologist

Julie Stachowiak

Vice President of Sales & Account Management

Irene Hahn

Senior Vice President Global Sales

Joseph Authement

Vice President of Supply Chain & Manufacturing

Rodger Mack

Chief Operating Officer & Chief Financial Officer

Paul Froutan

Chief Technical Advisor

Paul Froutan


neworleanscitybusiness - Jan, 8 2016

High-tech robot at Jesuit takes aim at campus germs

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: